Tharimmune, a company listed in the United States, has filed a definitive additional materials proxy statement with the Securities and Exchange Commission (SEC). This filing, known as Schedule 14A, is a requirement under Section 14(a) of the Securities Exchange Act of 1934 and is used to provide shareholders with information necessary to vote on important company matters. Tharimmune has confirmed that no filing fee was required for this submission. The materials filed are definitive, meaning they are the final version provided to shareholders for their consideration.

Tharimmune, a company listed in the United States, has filed a definitive additional materials proxy statement with the Securities and Exchange Commission (SEC). This filing, known as Schedule 14A, is a requirement under Section 14(a) of the Securities Exchange Act of 1934 and is used to provide shareholders with information necessary to vote on important company matters. Tharimmune has confirmed that no filing fee was required for this submission. The materials filed are definitive, meaning they are the final version provided to shareholders for their consideration.